ライフサイエンスコーパス: T-regulatory cell

1 ion, despite a systemic increase in FoxP3(+) T regulatory cells.

2 d no GVHD with expanded donor and host Foxp3 T regulatory cells.

3 t expansion of Th17 cells and a reduction in T regulatory cells.

4 DO1 represents an effective tool to generate T regulatory cells.

5 olecule present on a subset of human natural T regulatory cells.

6 of CD8(+) T effector cells to CD4(+)FoxP3(+) T regulatory cells.

7 rinsic, with no detectable effects on Th1 or T regulatory cells.

8 r gut homeostasis and maintenance of colonic T regulatory cells.

9 survival, function, and expansion of type 1 T regulatory cells.

10 t barrier integrity and increased intestinal T regulatory cells.

11 suppressor cells, tolerogenic monocytes, and T regulatory cells.

12 nhancing the development of Foxp3(+)-induced T regulatory cells.

13 L-2 induces organ pathology and expansion of T regulatory cells.

14 g dependent and IL-2-nano-APC did not affect T regulatory cells.

15 ntiation, and downregulates the induction of T regulatory cells.

16 of IRIS was not influenced by the levels of T regulatory cells.

17 insic unresponsiveness and the activation of T regulatory cells.

18 e IFN-gamma production by expanding FoxP3(+) T regulatory cells.

19 educed CD73 expression in Th17 and inducible T regulatory cells.

20 d function of DEPTOR within recipient CD4(+) T regulatory cells.

21 heir nodes, males had a higher percentage of T regulatory cells.

22 cytes and in increased thymic and peripheral T regulatory cells.

23 ted T conventional cells into CD4(+)Foxp3(+) T regulatory cells.

24 is mediated by both conventional and induced T regulatory cells.

25 This profile was not observed for natural T regulatory cells.

26 igration of purified CD4(+)CD25(+)CD127(dim) T regulatory cells.

27 ss the endothelial barrier at the expense of T regulatory cells.

28 ctions in differentiated CD4(+) T helper and T regulatory cells.

29 NAs, compared with wild-type mice, and fewer T-regulatory cells.

30 d a relative bias toward suppressive Th2 and T-regulatory cells.

31 fferentiation, in particular T-helper 17 and T-regulatory cells.

32 e unique T-cell subset, composed of Foxp3(+) T-regulatory cells.

33 nd increased levels of CD4(+)CD25(+)Foxp3(+) T-regulatory cells.

34 and CD8(+) T-effector cells to CD4(+)CD25(+) T-regulatory cells.

35 DAA therapy increased patients' numbers of T-regulatory cells (1.5% +/- 0.18% before therapy vs 2.1

36 APCs, blood-brain barrier permeability, and T regulatory cell activity, respectively.

37 An increase in myeloid and T regulatory cells and a decrease in NK and T cytotoxic

38 PN reduces lamina propria activated and T regulatory cells and also naive and memory B cells.

39 At week 12, increased peripheral-blood T regulatory cells and decreased antigen-specific T cell

40 ntial for the development and maintenance of T regulatory cells and for activation-induced cell death

41 y increased the frequency of thymic Foxp3(+) T regulatory cells and Foxp3(-)FR4(hi)CD73(hi) anergic p

42 f food allergy through induction of IL-10(+) T regulatory cells and indirect stabilization of mast ce

43 Of the cell subsets investigated, T regulatory cells and M0 and M2 macrophages emerged as

44 ity of the vaccine to reduce infiltration of T regulatory cells and myeloid-derived suppressor cells.

45 h factor-beta (proTGFbeta) on the surface of T regulatory cells and platelets; however, whether GARP

46 nd elicited proportionally less expansion of T regulatory cells and reduced pulmonary oedema.

47 This programmed DCs to induce FOXP3(+) T regulatory cells and suppressed production of proinfla

48 evels of SIV DNA to CXCR5(-)CCR7(+) "T zone" T regulatory cells and TFH.

49 on of AhR-KO mice resulted in an increase in T regulatory cells and transforming growth factor beta,

50 increased abundance of TAMs and intratumoral T-regulatory cells and decreased abundance of CD8(+) tum

51 levels of blood- and brain-resident Foxp3(+) T-regulatory cells and display an alteration in the infl

52 bers of myeloid-derived suppressor cells and T-regulatory cells and increased T-helper 1 and 17 respo

53 UMSCs also induced the maturation of T-regulatory cells and led to inflammatory cell death.

54 of Enterobacteriaceae, increased numbers of T-regulatory cells and levels of CX3CR1 protein and Il10

55 es revealed higher percentages of CD8(+) and T-regulatory cells and lower percentages of B cells.

56 rogrammed death ligand-1 and accumulation of T-regulatory cells and M2-type macrophages.

57 Comparable elevations of T-regulatory cells and myeloid-derived suppressor cells

58 follows: 1) induction of IL-10 and FOXP3(+) T regulatory cells, and 2) suppression of proinflammator

59 PDL1 and CTLA4, increased tumor-infiltrating T regulatory cells, and decreased natural killer (NK) ce

60 er, reduced numbers of CD4(+)CD25(+)Foxp3(+) T regulatory cells, and dysregulated NK cell and CD4(+)

61 es, including cancer-associated fibroblasts, T regulatory cells, and inflammatory mediators.

62 conversion of CD4+CD25- T cells to CD4+CD25+ T regulatory cells, and KLF10 target gene expression.

63 with a focus on hematopoietic malignancies, T regulatory cells, and other immune system cells.

64 mokine receptor type 5(+) (CCR5(+)) T cells, T regulatory cells, and T-helper 17 cells were unaltered

65 ry mechanisms, such as inhibitory receptors, T regulatory cells, and the anti-inflammatory cytokine,

66 ole in gut inflammation and the induction of T regulatory cells, and the short chain fatty acids (SCF

67 subpopulations of T cells, such as Th17 and T regulatory cells, and to define their role in SLE.

68 igh-dose allergen exposure models in humans, T regulatory cells are essential in the suppression of T

69 This study tests whether Foxp3(+) T-regulatory cells are responsible in the early phase of

70 states include Th1, Th2, Th17, and Foxp3(+) T regulatory cells, as well as the more recently describ

71 ed the induction and maintenance of Foxp3(+) T regulatory cells, as well as their in vitro suppressiv

72 ) T-helper cells but not with an increase in T-regulatory cells, as observed in the vemurafenib-only

73 kines and Chemokines, (vi) Cellular markers (T regulatory cells, B regulatory cells and dendritic cel

74 arthritis through the regulation of the Th17/T-regulatory cell balance and osteoclastogenesis.

75 nistic probes for KLF10-mediated effects and T regulatory cell biology.

76 ction was associated with increased adaptive T regulatory cells but not natural regulatory T cells in

77 GITR expression was highest on T regulatory cells but was also detected on Th1 and LCMV

78 jury by IL-33 correlated with an increase in T regulatory cells but with a decrease in macrophages, d

79 rkhead box P3 (FOXP3) is well-established in T-regulatory cells, but the function of transient FOXP3

80 contributes to the function of CD4(+)CD25(+) T regulatory cells by enhancing immune suppression, both

81 l focus on enhancing the clinical benefit of T-regulatory cells by increasing their number and streng

82 Dominant tolerance imposed by CD4(+)Foxp3(+) T regulatory cells can actively control autoaggressive T

83 We also found increased levels of T regulatory cells (CD25(+)CD127(-)) in the spleen and m

84 ver, infiltrating T cells were predominantly T-regulatory cells (CD25+/Forkhead Box P3 [FoxP3+]).

85 erved an induction of regulatory cells (CD4+ T regulatory cells; CD8+ T suppressor cells) and of T me

86 g SMC showed greater increases in CD4+FOXP3+ T regulatory cells compared to children not receiving SM

87 ficantly reduced lamina propria CD4CD25Foxp3 T regulatory cells compared with chow-fed mice, whereas

88 ratumoral T effector cells to CD4(+)FoxP3(+) T regulatory cells, compared with monotherapy.

89 utant mice demonstrate a twofold increase in T-regulatory cells, consistent with induction of immune

90 ddressed whether alteration in the levels of T regulatory cells contributed to the development of IRI

91 ter reports that adoptive immunotherapy with T-regulatory cells controls the alloreactivity of conven

92 characterized by increased allergen-specific T regulatory cells, decreased circulating Fel d 1 tetram

93 The epigenetic transmittance of adaptive T regulatory cell deficiency is demonstrated throughout

94 ation (dextran sodium sulphate treatment and T regulatory cell depletion using C57BL/6-FoxP3(DTR) mic

95 t improve antigen-specific T cell expansion, T regulatory cell depletion, or effector T cell function

96 ty have been noted to result from defects in T regulatory cell, development and function.

97 ically regulate the acquisition of CD4+CD25+ T regulatory cell differentiation and function, an effec

98 d FOXP3 induction and inappropriate adaptive T regulatory cell differentiation results in vitro and i

99 4 pathway in DCs and programs them to drive T regulatory cell differentiation.

100 may involve augmentation of TGF-beta-induced T regulatory cell differentiation.

101 head box P3 (Foxp3) locus during the induced T regulatory cell differentiation.

102 s with MDS-PA have altered hematopoiesis and T regulatory cell distribution in the tumor microenviron

103 nse by augmenting both T-helper-1-driven and T-regulatory-cell-driven inflammatory responses in the l

104 cell subsets (Th1, Th2, Th17, and inducible T-regulatory cells), each of which has specialized funct

105 Tregitopes (T regulatory cell epitopes) are natural T cell epitopes

106 ding Th2 skewing and reduced IL-10-secreting T regulatory cells, exaggerated with additional allergen

107 lows overgrowth of Lactobacilli and triggers T regulatory cell expansion in the gut.

108 , consisting of proinflammatory monocyte and T regulatory cell expansion.

109 A+ CD161+ effector memory T cells and IL17A+ T-regulatory cells; expansion of HLA-DR+CD56+ granulocyt

110 erapy with tolerogenic donor-specific type 1 T regulatory cells for patients with type 1 diabetes und

111 erance cannot occur in murine models lacking T regulatory cells, for which Foxp3+ is a key marker.

112 ioamnionitis clearly associated with reduced T regulatory cell frequencies and functional characteris

113 iated with reduced Th2, Th17, and FOXP3+CD4+ T regulatory cell frequencies in VL patient blood.

114 imited and important cell populations (e.g., T regulatory cells) from disease conditions or in diseas

115 A number of other gene defects that affect T regulatory cell function also give rise to IPEX-relate

116 The tolerogenic cytokine IL9 promotes T regulatory cell function and allergic airway inflammat

117 spectrum of genetic defects that compromise T regulatory cell function underlies human disorders of

118 JNK phosphorylation plays a central role in T regulatory cell function with therapeutic implications

119 taining T cell homeostasis as well as normal T regulatory cell function, thereby controlling abnormal

120 or suppressor gene and a master regulator in T regulatory cell function.

121 logical functions, including cardiac growth, T-regulatory cell function, neuronal disorders, muscle d

122 Human CD4+CD25+Foxp3+ T regulatory cells (huTreg) suppress CD4+ T cell-mediate

123 l therapy, patients had increased numbers of T-regulatory cells, IgM+CD21-/low-memory B cells, CD4+CX

124 by other monocyte subsets and enhance CD4(+) T regulatory cell IL-10 expression.

125 ls from patients with CD had increased IL1B+ T-regulatory cells, IL1B+ DCs and IL1B+ plasmacytoid DCs

126 A sustained rise in CD39(+) T regulatory cells, immunosuppressive CD56(hi) natural k

127 shown that CD4(+) T-cells, especially CD4(+) T-regulatory cells, improve wound healing after MI, wher

128 us altering the ratio of donor T effector to T regulatory cells in favor of reducing the pathological

129 es showed intense peri-islet infiltration of T regulatory cells in long-term grafts and systemic depl

130 cterized TFR as CXCR5(+)CCR7(-) "follicular" T regulatory cells in lymphoid tissues of healthy rhesus

131 the polarization of Th1, Th17, and possibly T regulatory cells in PDAC tumors.

132 ed infiltration of activated macrophages and T regulatory cells in skin and digit joints as well as b

133 ter constitutive phosphorylation of STAT5 in T regulatory cells in spleen cells compared with mice tr

134 and highlight the key role for TGF-beta1 and T regulatory cells in the establishment and maintenance

135 e selection including elimination of natural T regulatory cells in the thymus.

136 with anti-CD40/CpG + IC/anti-CTLA-4 reduced T regulatory cells in the tumors and was effective again

137 a reduction in the number of CD4(+)FoxP3(+) T regulatory cells in the tumors.

138 ge, SHIV-immunized RM had significantly more T regulatory cells in the vagina than the unimmunized RM

139 IL-10 conversion of CD4 T cells to CD4 FoxP3 T regulatory cells in vitro, and DHA-treated M2 macropha

140 They find that DHA induces FoxP3 T regulatory cells in vivo, M2 macrophages drive transfo

141 eukin 10 and FOXP3, and increased follicular T-regulatory cells in pretreatment mice.

142 cantly reduced the numbers of CD4(+)Foxp3(+) T-regulatory cells in the tissue.

143 nd consequent induction of immunosuppressive T-regulatory cells in tumor tissue promote immune tolera

144 ivers, LSECs are active in the generation of T regulatory cells, in hepatic fibrosis LSECs induce an

145 tivation of CD4 T cells, as well as FOXP3(+) T regulatory cells, in response to YFV vaccination prece

146 CD4(+) T-cell lineages, Th1, Th2, Th17, and T-regulatory cells, in their gene expression profiles.

147 eficit in CD4(+) TCRbeta(+) Foxp3(+) CD25(+) T regulatory cells, increased IL-6 and IL-17 production

148 These data identify the critical role of CD8-T regulatory cell interactions in regulating the suppres

149 thogen recognition receptors in human FOXP3+ T regulatory cells is established, yet the function of t

150 hat the balance between T-helper (Th) 17 and T-regulatory cells is an important factor in toxoplasmos

151 n response to fetal tissue, and depletion of T regulatory cells led to an increase in fetal-specific

152 ions of solid organ transplantation and that T-regulatory cells may function toward maintenance of th

153 eted T cells acquire intrinsic resistance to T regulatory cell-mediated inhibition.

154 iate ratio of conventional T lymphocytes and T-regulatory cells, natural killer cells, gamma delta T

155 Naturally occurring Foxp3(+)CD4(+)CD25(+) T regulatory cell (nTreg)-mediated suppression of lung a

156 d, genetically targeted and expanded natural T regulatory cells (nTreg).

157 ctivity of CD4(+)CD25(+) naturally occurring T regulatory cells (nTregs) in wild-type (WT) hosts.

158 y elevated TGF-beta1 and high nasopharyngeal T regulatory cell numbers, is crucial for prolonged carr

159 not associated with differences in levels of T regulatory cells or baseline pro-inflammatory cytokine

160 numbers of IgM+CD21-/low memory B cells and T-regulatory cells (P = .03), and positive correlations

161 teronyssinus-induced CD4(+) CD25(+) FOXP3(+) T regulatory cell percentage, intracellular Foxp3 expres

162 oting FoxP3(+)RoRgammat(+)IL17(+) pathogenic T-regulatory cells (pgTreg), with a concomitant restorat

163 smokers' and nonsmokers' AM induced FoxP3(+) T regulatory cell phenotype responses in allogeneic admi

164 nitial experiment 1 protocol, lamina propria T regulatory cell phenotype was evaluated by Foxp3 expre

165 numbers of CD4(+) T cells of T-helper 2 and T-regulatory cell phenotypes.

166 e into pathogenic Th1 and Th17 or protective T regulatory cells plays a pivotal role in the pathogene

167 included serum creatinine (SCr), peripheral T-regulatory cells (pTregs)(127/CD4+/25), and DSA for gr

168 oral CD8(+) T effector/CD4(+)CD25(+)Foxp3(+) T regulatory cell ratio.

169 Th17 cytokines and exhibit skewed T effector/T regulatory cell ratios.

170 rization, along with increased T effector to T regulatory cell ratios.

171 epatitis infection with TGFbeta activity and T regulatory cell recruitment to establish a favorable m

172 oxyphenylalanine levels and the abundance of T regulatory cells regulated by DNA methylation.

173 Using reporter mice, we observed that these T regulatory cells released substantial amounts of IL-10

174 contrast to restoration of MDSCs, levels of T regulatory cells remained reduced in BRAFi-resistant t

175 med to investigate the efficacy, safety, and T regulatory cell response of vitamin D as an adjunct to

176 The T regulatory cell response to immune activation increase

177 , roles for IL-33 in promoting CD8, Th1, and T regulatory cell responses have also emerged.

178 The percentage of LP T regulatory cells significantly decreased with TPN in W

179 t induced expression of DEPTOR within CD4(+) T regulatory cells stabilizes Foxp3 expression, shifts m

180 d CD4(+) T cell responses and alterations in T regulatory cells (T(reg) cells) play a critical role i

181 a chemokine associated with infiltration of T regulatory cells (T(reg)).

182 t interactions with T cells, either inducing T regulatory cells (T(REG)s) or causing anergy.

183 s to support negative selection and Foxp3(+) T-regulatory cell (T-reg) development.

184 poptosis of CD8+ T cells and infiltration of T-regulatory cells (T(reg)).

185 tudies have identified an effector subset of T regulatory cells termed T follicular regulatory (Tfr)

186 in higher levels of class I in CD4(+)CD25(+) T regulatory cells than in conventional CD4(+)CD25(-) T

187 Ag-SP infusion also induces T regulatory cells that are dispensable for tolerance in

188 T regulatory cells that express the transcription factor

189 bundances of HLA-DR+CD38+ T cells, including T-regulatory cells that produce inflammatory cytokines;

190 higher expression of 24-hydroxylase than Th2/T regulatory cells, that was reverted by LOV or ROCK inh

191 ilar proportions of CD86(+) DCs and Foxp3(+) T regulatory cells, the SP-A(-/-) mice had elevated prop

192 ors to subvert proinflammatory signaling via T regulatory cells, thereby inducing anti-inflammatory e

193 vel, both mDCs and plasmacytoid DCs generate T regulatory cells through an IDO1/IDO2-dependent mechan

194 city may augment suppression of Th2 cells by T regulatory cells, through mechanisms that involve T ce

195 e product (WASP) serves an essential role in T regulatory cells to contain Th2 effector cell differen

196 newly identified inhibitory cytokine used by T regulatory cells to control T cell-driven immune respo

197 anism that involves IL-10 and CD4(+)FoxP3(+) T regulatory cells to dampen exaggerated mucosal inflamm

198 le of inducing in T lymphocytes, the pivotal T regulatory cell transcription factor forkhead box P3 (

199 l immunosuppression were observed, including T regulatory cell (Treg) co-localization with CD8 T cell

200 (TGF-beta) and concomitantly an increase in T regulatory cell (Treg) function.

201 depleting and destabilizing the intratumoral T regulatory cell (Treg) population, the precise mechani

202 art mediated through induction of a FoxP3(+) T regulatory cell (Treg) response.

203 d (CB) fetal T cell differentiation into key T regulatory cell (Treg) subsets.

204 CD4 T cells, including T regulatory cells (Treg cells) and effector T helper ce

205 A proper balance between Th17 and T regulatory cells (Treg cells) is critical for generati

206 e possibility that simultaneous expansion of T regulatory cells (Treg) and T effector cells early pos

207 TGFbeta and IL10 favored generation of T regulatory cells (Treg) and Th2-oriented responses tha

208 T regulatory cells (Treg) avert autoimmunity, but their

209 The overwhelming body of research on T regulatory cells (Treg) has focused on CD4 + CD25 + Fo

210 f Th2 responses in allergic disease, whereas T regulatory cells (Treg) have been shown to suppress pr

211 cells regulated the number of CD4(+)Foxp3(+) T regulatory cells (Treg) in the CNS during EAE.

212 The accumulation of CD4(+) T regulatory cells (Treg) in tumor tissue is a widely de

213 and preferentially induced the expansion of T regulatory cells (Treg) in vitro and in vivo Targeted

214 er, in the clinical setting, CD4(+) CD25(hi) T regulatory cells (Treg) present within the tumor micro

215 hanism involves the accumulation of FOXP3(+) T regulatory cells (Treg), a class of suppressive T cell

216 lockade reduced accumulation of intratumoral T regulatory cells (Treg), but it was insufficient to su

217 , the absolute cell number of CD4(+)Foxp3(+) T regulatory cells (Treg), essential for immune toleranc

218 Before this therapy was initiated, T regulatory cells (Treg), Th17, and granulocytic myeloi

219 le for it in mediating recruitment of CD4(+) T regulatory cells (Treg).

220 recent advances in the fields of intestinal T-regulatory cell (Treg) and tolerogenic dendritic cell

221 viral adaptive responses and contributing to T-regulatory cell (Treg) development.

222 Anti-CTLA4 predominantly inhibits T-regulatory cells (Treg cells), thereby increasing the

223 rease the frequency of CD4(+)CD25(+)FoxP3(+) T-regulatory cells (Treg) relative to conventional T cel

224 cancer requires recruitment and expansion of T-regulatory cells (Treg) that promote escape from host

225 of FoxP3(+)RoRgammat(-)IL17(-) conventional T-regulatory cells (Treg).

226 ively re-adding CD4(+) CD25(bright) T cells (T regulatory cells, Treg), their effect on drug-specific

227 ects on either the donor T effector cells or T regulatory cells Tregs in vitro.

228 effect of vitamin D on lung histology, AHR, T regulatory cells (Tregs) and BALF cytokines was examin

229 selective deficiency of DOCK8 in T cells or T regulatory cells (Tregs) and found that both have exag

230 functional imbalances in the frequencies of T regulatory cells (Tregs) and interleukin 17 (IL-17)/IL

231 minate immunosuppressive populations such as T regulatory cells (Tregs) and myeloid-derived suppresso

232 Thymic-derived natural T regulatory cells (Tregs) are characterized by function

233 T regulatory cells (Tregs) are critical in shaping the l

234 Foxp3(+) T regulatory cells (Tregs) are critically important for

235 Forkhead box P3(+) T regulatory cells (Tregs) are key players in maintainin

236 ng adoptive transfer models, we find that KO T regulatory cells (Tregs) are less efficient in suppres

237 Probiotic group coincided with higher ileal T regulatory cells (Tregs) before and after challenge, a

238 FOXP3-expressing T regulatory cells (Tregs) can be divided into two disti

239 were resistant to killing by CD4(+)Foxp3(+) T regulatory cells (Tregs) compared with wild-type DCs.

240 itic cells (DCs), self-reactive T cells, and T regulatory cells (Tregs) contribute to maintaining mam

241 T regulatory cells (Tregs) control immune homeostasis by

242 Activated T regulatory cells (Tregs) express latent TGF-beta1 on t

243 T regulatory cells (Tregs) have been associated with pro

244 and expands the numbers of immunomodulatory T regulatory cells (Tregs) in animal models.

245 T regulatory cells (Tregs) in the spleen, pancreatic isl

246 Reduced T regulatory cells (Tregs) inversely correlate with arth

247 ever proven in vivo, that the eye can induce T regulatory cells (Tregs) locally.

248 ntering SAg-mediated T cell activation using T regulatory cells (Tregs) might be beneficial in diseas

249 T regulatory cells (Tregs) play a critical role in contr

250 Notably, T regulatory cells (Tregs) showed significantly lower ex

251 In the healthy setting, CD8 T regulatory cells (Tregs) terminate ongoing T-B interac

252 Allergic conjunctivitis did affect T regulatory cells (Tregs) that support graft survival.

253 ogrammed cell death 1 (PD-1) is critical for T regulatory cells (Tregs) to maintain peripheral tolera

254 nsplantation, we reported that donor-derived T regulatory cells (Tregs), coinfused with conventional

255 Foxp3(+) T regulatory cells (Tregs), conventional CD4(+)Foxp3(-)

256 We evaluated T regulatory cells (Tregs), myeloid-derived suppressor c

257 use prevents autoimmune attack by recruiting T regulatory cells (Tregs), protecting mice from diabete

258 ically address the effects of type I IFNs on T regulatory cells (Tregs), we studied mixed bone marrow

259 chanisms that include enhanced regulation by T regulatory cells (Tregs).

260 yzed early events and selective depletion of T regulatory cells (Tregs).

261 r T cells and opposing inhibitory effects on T regulatory cells (Tregs).

262 mouse by promoting the local recruitment of T regulatory cells (Tregs).

263 ice by generating InsB9-23-specific FoxP3(+) T regulatory cells (Tregs).

264 ciency of tolerance-inducing CD4+CD25+FoxP3+ T regulatory cells (Tregs).

265 , IL-12p70, IL-10, TGF-beta, and IL-17), and T regulatory cells (Tregs).

266 tuberculosis-expanded CD4(+)CD25(+)FOXP3(+) T regulatory cells (Tregs).

267 numbers and function of CD4+CD25(high)FOXP3+ T regulatory cells (Tregs).

268 cells (Tfhs), and forkhead box P3 (Foxp3)(+) T regulatory cells (Tregs).

269 d whether their function is coordinated with T regulatory cells (Tregs).

270 crophages were unable to sufficiently induce T regulatory cells (Tregs).

271 ts and limited efficacy due to activation of T regulatory cells (Tregs).

272 g inducing anti-inflammatory IL-10-secreting T regulatory cells (Tregs).

273 nfection by bystander immune cells including T-regulatory cells (Tregs) and natural killer (NK) cells

274 T-regulatory cells (Tregs) are found infiltrating tumors

275 Foxp3(+) T-regulatory cells (Tregs) are key to immune homeostasis

276 Foxp3(+) T-regulatory cells (Tregs) are primarily generated in th

277 ibular lymph node CD4(+) cells became robust T-regulatory cells (Tregs) in WT forkhead box P3 (Foxp3)

278 BACKGROUND & AIMS: Foxp3(+) T-regulatory cells (Tregs) maintain intestinal homeostas

279 T-regulatory cells (Tregs), a subset of CD4+ T cells, ha

280 tress, regulating survival in murine natural T-regulatory cells (Tregs), an immune subset controlling

281 important in CD4 T-effector and/or Foxp3(+) T-regulatory cells (Tregs), and we found that B10.S-Eae5

282 /gal-9 was inhibited in the absence of donor T-regulatory cells (Tregs), GVHD was inhibited.

283 nders had increased IL-10-producing FOXP3(+) T regulatory cells upon vaccination, only in hepatitis B

284 (+) T cells, the differentiation of Foxp3(+) T regulatory cells was suppressed, whereas Th17 cells we

285 tion of T-helper (Th1) cells, Th2 cells, and T-regulatory cells was determined by nuclear staining fo

286 lightly prevalent over Th2, whereas Th17 and T regulatory cells were <1%.

287 Frequencies of Foxp3 T regulatory cells were comparable in both surviving and

288 ry cells were higher, while CD25(+) Foxp3(+) T regulatory cells were lower.

289 The levels of T regulatory cells were measured using flow cytometry at

290 T regulatory cells were nearly abolished and antitumor i

291 c CD3(+) alphabeta TCR(+) cells and Foxp3(+) T regulatory cells were present in DKO mice but signific

292 T regulatory cells were significantly decreased in AA pa

293 hocytes in the draining lymph nodes, whereas T-regulatory cells were dampened.

294 In mixed chimeras, increased numbers of T-regulatory cells were found in draining compared with

295 Elevated levels of CD3+ FoxP3+ T-regulatory cells were found in skin and muscle of vasc

296 n and muscle, elevated levels of CD3+ FoxP3+ T-regulatory cells were found in the skin and muscle obt

297 ced vascular oxidative stress while FoxP3(+) T-regulatory cells were unaltered.

298 hanges, together with reduced recruitment of T regulatory cells, were associated with higher ratios o

299 MPL monotherapy was restored by depletion of T regulatory cells, whereas eliminating CD8(+) T cells a

300 pathology, 9142-primed mice also had splenic T regulatory cells with greater suppressive activity tha